{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:47:29Z","timestamp":1791402449708,"version":"4.3.3"},"reference-count":51,"publisher":"Oncology Nursing Society (ONS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ONF"],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.1188\/21.onf.229-241","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T13:21:48Z","timestamp":1613654508000},"page":"229-241","source":"Crossref","is-referenced-by-count":9,"title":["Genitourinary Symptoms in Breast Cancer Survivors: Prevalence, Correlates, and Relationship With Sexual Functioning"],"prefix":"10.1188","volume":"48","author":[{"given":"Ying","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cohee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Stump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aydin, Y., Hassa, H., Oge, T., Yalcin, O.T., & Mutlu, F.\u015e. (2014). Frequency and determinants of urogenital symptoms in postmenopausal Islamic women. Menopause, 21(2), 182\u2013187. https:\/\/doi.org\/10.1097\/GME.0b013e3182937966","DOI":"10.1097\/GME.0b013e3182937966"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bair, M.J., Robinson, R.L., Katon, W., & Kroenke, K. (2003). Depression and pain comorbidity: A literature review. Archives of Internal Medicine, 163(20), 2433\u20132445. http:\/\/doi.org\/10.1001\/archinte.163.20.2433","DOI":"10.1001\/archinte.163.20.2433"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Baumgart, J., Nilsson, K., Evers, A.S., Kallak, T.K., & Sundstr\u00f6m-Poromaa, I. (2013). Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause, 20(2), 162\u2013168. https:\/\/doi.org\/10.1097\/gme.0b013e31826560da","DOI":"10.1097\/GME.0b013e31826560da"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Baumgart, J., Nilsson, K., Stavreus-Evers, A., Kask, K., Villman, K., Lindman, H., . . . Sundstr\u00f6m-Poromaa, I. (2011). Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. American Journal of Obstetrics and Gynecology, 204(1), 26.e1\u201326.e7. https:\/\/doi.org\/10.1016\/j.ajog.2010.08.035","DOI":"10.1016\/j.ajog.2010.08.035"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ben Charif, A., Bouhnik, A.D., Rey, D., Provansal, M., Courbiere, B., Spire, B., & Mancini, J. (2015). Satisfaction with fertility- and sexuality-related information in young women with breast cancer\u2014ELIPPSE40 cohort. BMC Cancer, 15, 527. http:\/\/doi.org\/10.1186\/s12885-015-1542-0","DOI":"10.1186\/s12885-015-1542-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Biglia, N., Bounous, V.E., D\u2019Alonzo, M., Ottino, L., Tuninetti, V., Robba, E., & Perrone, T. (2017). Vaginal atrophy in breast cancer survivors: Attitude and approaches among oncologists. Clinical Breast Cancer, 17(8), 611\u2013617. https:\/\/doi.org\/10.1016\/j.clbc.2017.05.008","DOI":"10.1016\/j.clbc.2017.05.008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Biglia, N., Pup, L.D., Masetti, R., Villa, P., & Nappi, R.E. (2020). Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: Results of an Italian Delphi Panel. Supportive Care in Cancer, 28(6), 2507\u20132512. https:\/\/doi.org\/10.1007\/s00520-019-05272-4","DOI":"10.1007\/s00520-019-05272-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Bober, S.L., & Varela, V.S. (2012). Sexuality in adult cancer survivors: Challenges and intervention. Journal of Clinical Oncology, 30(30), 3712\u20133719. https:\/\/doi.org\/10.1200\/JCO.2012.41.7915","DOI":"10.1200\/JCO.2012.41.7915"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Boquiren, V.M., Esplen, M.J., Wong, J., Toner, B., Warner, E., & Malik, N. (2016). Sexual functioning in breast cancer survivors experiencing body image disturbance. Psycho-Oncology, 25(1), 66\u201376. http:\/\/doi.org\/10.1002\/pon.3819","DOI":"10.1002\/pon.3819"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Bubis, L.D., Davis, L., Mahar, A., Barbera, L., Li, Q., Moody, L., . . . Coburn, N.G. (2018). Symptom burden in the first year after cancer diagnosis: An analysis of patient-reported outcomes. Journal of Clinical Oncology, 36(11), 1103\u20131110. https:\/\/doi.org\/10.1200\/JCO.2017.76.0876","DOI":"10.1200\/JCO.2017.76.0876"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Burich, R., & DeGregorio, M. (2011). Current treatment options for vulvovaginal atrophy. Expert Review of Obstetrics and Gynecology, 6(2), 141\u2013151. https:\/\/doi.org\/10.1586\/eog.11.3","DOI":"10.1586\/eog.11.3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Calleja-Agius, J., & Brincat, M.P. (2015). The urogenital system and the menopause. Climacteric, 18(1, Suppl.), 18\u201322. https:\/\/doi.org\/10.3109\/13697137.2015.1078206","DOI":"10.3109\/13697137.2015.1078206"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Champion, V.L., Wagner, L.I., Monahan, P.O., Daggy, J., Smith, L., Cohee, A., . . . Sledge, G.W., Jr. (2014). Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer, 120(15), 2237\u20132246. https:\/\/doi.org\/10.1002\/cncr.28737","DOI":"10.1002\/cncr.28737"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Champion, V.L., Ziner, K.W., Monahan, P.O., Stump, T.E., Cella, D., Smith, L.G., . . . Sledge, G.W. (2013). Development and psychometric testing of a breast cancer survivor self-efficacy scale. Oncology Nursing Forum, 40(6), E403\u2013E410. https:\/\/doi.org\/10.1188\/13.ONF.E403-E410","DOI":"10.1188\/13.ONF.E403-E410"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Chin, S.N., Trinkaus, M., Simmons, C., Flynn, C., Dranitsaris, G., Bolivar, R., & Clemons, M. (2009). Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clinical Breast Cancer, 9(2), 108\u2013117. https:\/\/doi.org\/10.3816\/CBC.2009.n.020","DOI":"10.3816\/CBC.2009.n.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Chung, C.P., Behrendt, C., Wong, L., Flores, S., & Mortimer, J.E. (2020). Serial assessment of urinary incontinence in breast cancer survivors undergoing (neo)adjuvant therapy. Journal of the National Comprehensive Cancer Network, 18(6), 712\u2013716. https:\/\/doi.org\/10.6004\/jnccn.2020.7535","DOI":"10.6004\/jnccn.2020.7535"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Constantine, G.D., Bruyniks, N., Princic, N., Huse, D., Palmer, L., Lenhart, G., . . . Nappi, R.E. (2014). Incidence of genitourinary conditions in women with a diagnosis of vulvar\/vaginal atrophy. Current Medical Research and Opinion, 30(1), 143\u2013148. https:\/\/doi.org\/10.1185\/03007995.2013.850068","DOI":"10.1185\/03007995.2013.850068"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Cook, E.D., Sutherland, E.I., Baum, G.P., Schover, L.L., & Newman, L.L. (2018). Missing documentation in breast cancer survivors: Genitourinary syndrome of menopause. Menopause, 24(12), 1360\u20131364. https:\/\/doi.org\/10.1097\/GME.0000000000000926","DOI":"10.1097\/GME.0000000000000926"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Crean-Tate, K.K., Faubion, S.S., Pederson, H.J., Vencill, J.A., & Batur, P. (2020). Management of genitourinary syndrome of menopause in female cancer patients: A focus on vaginal hormonal therapy. American Journal of Obstetrics and Gynecology, 222(2), 103\u2013113. https:\/\/doi.org\/10.1016\/j.ajog.2019.08.043","DOI":"10.1016\/j.ajog.2019.08.043"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Gandhi, J., Chen, A., Dagur, G., Suh, Y., Smith, N., Cali, B., & Khan, S.A. (2016). Genitourinary syndrome of menopause: An overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. American Journal of Obstetrics and Gynecology, 215(6), 704\u2013711. https:\/\/doi.org\/10.1016\/j.ajog.2016.07.045","DOI":"10.1016\/j.ajog.2016.07.045"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Geerlings, M.I., Ruitenberg, A., Witteman, J.C., van Swieten, J.C., Hofman, A., van Duijn, C.M., . . . Launer, L.J. (2001). Reproductive period and risk of dementia in postmenopausal women. JAMA, 285(11), 1475\u20131481. http:\/\/doi.org\/10.1001\/jama.285.11.1475","DOI":"10.1001\/jama.285.11.1475"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Geng, L., Zheng, Y., Zhou, Y., Li, C., & Tao, M. (2018). The prevalence and determinants of genitourinary syndrome of menopause in Chinese mid-life women: A single-center study. Climacteric, 21(5), 478\u2013482. https:\/\/doi.org\/10.1080\/13697137.2018.1458832","DOI":"10.1080\/13697137.2018.1458832"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Gupta, P., Sturdee, D.W., Palin, S.L., Majumder, K., Fear, R., Marshall, T., & Paterson, I. (2006). Menopausal symptoms in women treated for breast cancer: The prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric, 9(1), 49\u201358. https:\/\/doi.org\/10.1080\/13697130500487224","DOI":"10.1080\/13697130500487224"},{"key":"24","unstructured":"Hosmer, D.W., Lemeshow, S., & Sturdivant, R.X. (2013). Applied logistic regression (3rd ed.). Wiley."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Hudson, W.W., Harrison, D.F., & Crosscup, P.C. (1981). A short-form scale to measure sexual discord in dyadic relationships. Journal of Sex Research, 17(2), 157\u2013174. https:\/\/doi.org\/10.1080\/00224498109551110","DOI":"10.1080\/00224498109551110"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kingsberg, S.A., Wysocki, S., Magnus, L., & Krychman, M.L. (2013). Vulvar and vaginal atrophy in postmenopausal women: Findings from the REVIVE (REal Women\u2019s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. Journal of Sexual Medicine, 10(7), 1790\u20131799. http:\/\/doi.org\/10.1111\/jsm.12190","DOI":"10.1111\/jsm.12190"},{"key":"27","unstructured":"Lenz, E.R., & Pugh, L.C. (2003). The theory of unpleasant symptoms. In M.J. Smith, & P.R. Liehr (Eds.), Middle range theory for nursing (pp. 165\u2013195). Springer."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Lenz, E.R., Pugh, L.C., Milligan, R.A., Gift, A., & Suppe, F. (1997). The middle-range theory of unpleasant symptoms: An update. Advances in Nursing Science, 19(3), 14\u201327. https:\/\/doi.org\/10.1097\/00012272-199703000-00003","DOI":"10.1097\/00012272-199703000-00003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Lester, J., Pahouja, G., Andersen, B., & Lustberg, M. (2015). Atrophic vaginitis in breast cancer survivors: A difficult survivorship issue. Journal of Personalized Medicine, 5(2), 50\u201366. https:\/\/doi.org\/10.3390\/jpm5020050","DOI":"10.3390\/jpm5020050"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Lester, J.L., & Bernhard, L.A. (2009). Urogenital atrophy in breast cancer survivors. Oncology Nursing Forum, 36(6), 693\u2013398. https:\/\/doi.org\/10.1188\/09.ONF.693-698","DOI":"10.1188\/09.ONF.693-698"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Lester, J.L., Bernhard, L., & Ryan-Wenger, N. (2012). A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. Western Journal of Nursing Research, 34(1), 72\u201396. https:\/\/doi.org\/10.1177\/0193945910391483","DOI":"10.1177\/0193945910391483"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Mac Bride, M.B., Rhodes, D.J., & Shuster, L.T. (2010). Vulvovaginal atrophy. Mayo Clinic Proceedings, 85(1), 87\u201394. https:\/\/doi.org\/10.4065\/mcp.2009.0413","DOI":"10.4065\/mcp.2009.0413"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Melisko, M.E., Goldman, M., & Rugo, H.S. (2010). Amelioration of sexual adverse effects in the early breast cancer patient. Journal of Cancer Survivorship, 4(3), 247\u2013255. https:\/\/doi.org\/10.1007\/s11764-010-0130-1","DOI":"10.1007\/s11764-010-0130-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Melisko, M.E., Goldman, M.E., Hwang, J., De Luca, A., Fang, S., Esserman, L.J., . . . Rugo, H.S. (2017). Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: A randomized clinical trial. JAMA Oncology, 3(3), 313\u2013319. http:\/\/doi.org\/10.1001\/jamaoncol.2016.3904","DOI":"10.1001\/jamaoncol.2016.3904"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Moral, E., Delgado, J.L., Carmona, F., Caballero, B., Guill\u00e1n, C., Gonz\u00e1lez, P.M., . . . Nieto, C. (2018). Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric, 21(2), 167\u2013173. https:\/\/doi.org\/10.1080\/13697137.2017.1421921","DOI":"10.1080\/13697137.2017.1421921"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Moyneur, E., Dea, K., Derogatis, L.R., Vekeman, F., Dury, A.Y., & Labrie, F. (2020). Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareunia. Menopause, 27(2), 134\u2013142. https:\/\/doi.org\/10.1097\/GME.0000000000001450","DOI":"10.1097\/GME.0000000000001450"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Nappi, R.E., Kingsberg, S., Maamari, R., & Simon, J. (2013). The CLOSER (CLarifying Vaginal Atrophy\u2019s Impact On SEx and Relationships) survey: Implications of vaginal discomfort in postmenopausal women and in male partners. Journal of Sexual Medicine, 10(9), 2232\u20132241. https:\/\/doi.org\/10.1111\/jsm.12235","DOI":"10.1111\/jsm.12235"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Nappi, R.E., & Kokot-Kierepa, M. (2010). Women\u2019s voices in the menopause: Results from an international survey on vaginal atrophy. Maturitas, 67(3), 233\u2013238. http:\/\/doi.org\/10.1016\/j.maturitas.2010.08.001","DOI":"10.1016\/j.maturitas.2010.08.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Nappi, R.E., & Kokot-Kierepa, M. (2012). Vaginal health: Insights, views & attitudes (VIVA)\u2014Results from an international survey. Climacteric, 15(1), 36\u201344. https:\/\/doi.org\/10.3109\/13697137.2011.647840","DOI":"10.3109\/13697137.2011.647840"},{"key":"40","doi-asserted-by":"crossref","unstructured":"North American Menopause Society. (2020). NAMS Position Statement: The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause, 27(9), 976\u2013992. http:\/\/doi.org\/10.1097\/GME.0000000000001609","DOI":"10.1097\/GME.0000000000001609"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Parish, S.J., Nappi, R.E., Krychman, M.L., Kellogg-Spadt, S., Simon, J.A., Goldstein, J.A., & Kingsberg, S.A. (2013). Impact of vulvovaginal health on postmenopausal women: A review of surveys on symptoms of vulvovaginal atrophy. International Journal of Women\u2019s Health, 5, 437\u2013447. https:\/\/doi.org\/10.2147\/IJWH.S44579","DOI":"10.2147\/IJWH.S44579"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Pavlovi\u0107, R.T., Jankovi\u0107, S.M., Milovanovi\u0107, J.R., Stefanovi\u0107, S.M., Foli\u0107, M.M., Milovanovi\u0107, O.Z., . . . Milosavljevi\u0107, M.N. (2019). The safety of local hormonal treatment for vulvovaginal atrophy in women with estrogen receptor-positive breast cancer who are on adjuvant aromatase inhibitor therapy: Meta-analysis. Clinical Breast Cancer, 19(6), e731\u2013e740. https:\/\/doi.org\/10.1016\/j.clbc.2019.07.007","DOI":"10.1016\/j.clbc.2019.07.007"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Portman, D.J., & Gass, M.L.S. (2014). Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society. Menopause, 21(10), 1063\u20131068. https:\/\/doi.org\/10.1097\/GME.0000000000000329","DOI":"10.1097\/GME.0000000000000329"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Rosen, R., Brown, C., Heiman, J., Leiblum, S., Meston, C., Shabsigh, R., . . . D\u2019Agostino, R. (2000). The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex and Marital Therapy, 26(2), 191\u2013208. https:\/\/doi.org\/10.1080\/009262300278597","DOI":"10.1080\/009262300278597"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Shi, Q., Smith, T.G., Michonski, J.D., Stein, K.D., Kaw, C., & Cleeland, C.S. (2011). Symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society\u2019s studies of cancer survivors. Cancer, 117(12), 2779\u20132790. https:\/\/doi.org\/10.1002\/cncr.26146","DOI":"10.1002\/cncr.26146"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Shifren, J.L., Zincavage, R., Cho, E.L., Magnavita, A., Portman, D.J., Krychman, M.L., . . . Rosen, R.C. (2019). Women\u2019s experience of vulvovaginal symptoms associated with menopause. Menopause, 26(4), 341\u2013349. https:\/\/doi.org\/10.1097\/GME.0000000000001275","DOI":"10.1097\/GME.0000000000001275"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Sousa, M.S., Peate, M., Jarvis, S., Hickey, M., & Friedlander, M. (2017). A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Therapeutic Advances in Medical Oncology, 9(4), 269\u2013285. https:\/\/doi.org\/10.1177\/1758834016687260","DOI":"10.1177\/1758834016687260"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Sousa, M.S., Peate, M., Lewis, C., Jarvis, S., Willis, A., Hickey, M., & Friedlander, M. (2018). Exploring knowledge, attitudes and experience of genitourinary symptoms in women with early breast cancer on adjuvant endocrine therapy. European Journal of Cancer Care, 27(2), e12820. https:\/\/doi.org\/10.1111\/ecc.12820","DOI":"10.1111\/ecc.12820"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Su, H.I., Stark, S., Kwan, B., Boles, S., Chingos, D., Ehren, J., . . . Natarajan, L. (2020). Efficacy of a web-based women\u2019s health survivorship care plan for young breast cancer survivors: A randomized controlled trial. Breast Cancer Research and Treatment, 176(3), 579\u2013589. http:\/\/doi.org\/10.1007\/s10549-019-05260-6","DOI":"10.1007\/s10549-019-05260-6"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Sussman, T.A., Kruse, M.L., Thacker, H.L., & Abraham, J. (2019). Managing genitourinary syndrome of menopause in breast cancer survivors receiving endocrine therapy. Journal of Oncology Practice, 15(7), 363\u2013370. https:\/\/doi.org\/10.1200\/JOP.18.00710","DOI":"10.1200\/JOP.18.00710"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Vincent, A.J. (2015). Management of menopause in women with breast cancer. Climacteric, 18(5), 690\u2013701. https:\/\/doi.org\/10.3109\/13697137.2014.996749","DOI":"10.3109\/13697137.2014.996749"}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/onf.ons.org\/onf\/48\/2\/genitourinary-symptoms-breast-cancer-survivors-prevalence-correlates-and-relationship","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:49:48Z","timestamp":1763754588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/48\/2\/genitourinary-symptoms-breast-cancer-survivors-prevalence-correlates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1188\/21.onf.229-241","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"value":"0190-535X","type":"print"},{"value":"1538-0688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}